Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Aptose Biosciences Establishes New At-the-Market Facility
-
FactSet Research Systems (FDS) PT Raised to $203 at Cantor Fitzgerald
-
IHS Markit (INFO) PT Raised to $51 at Cantor Fitzgerald
-
Allscripts (MDRX) Weakness Overdone - Cantor Fitzgerald
-
Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
-
M III Acquisition Corp. Completes Merger With IEA Services LLC
-
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
-
Freddie Mac Prices $667 Million Multifamily K-Deal
-
Auryn Resources Announces Closing of US$9.8 Million Financing
-
Cantor Fitzgerald Remains Overweight on Radius Health (RDUS) Following Negative EMA Vote
-
Prophotonix Posts 2017 Annual Report and Accounts
-
Arena Pharma (ARNA) Prices 8.5M Share Common Offering at $41.50/Sh
-
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Abeona Therapeutics (ABEO) PT Raised to $36 at Cantor Fitzgerald
-
Xencor (XNCR) Prices 7.3M Share Common Offering at $31/Sh
-
Tiberius Acquisition Corporation Announces Closing of $150,000,000 Initial Public Offering
-
Xencor Announces Pricing of Public Offering of Common Stock
-
Arena Pharma (ARNA) to Offer 7.5M Shares of Common Stock
-
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Arena Pharma (ARNA) PT Raised to $64 at Cantor Fitzgerald
-
HealthEquity, Inc (HQY) PT Raised to $65 at Cantor Fitzgerald Following 4Q
-
IPA Chapters Bring Education and Networking Directly to PDI Industry
-
Heron Therapeutics (HRTX) PT Raised to $40 at Cantor Fitzgerald
-
Hamilton Zanze and Cantor Fitzgerald Joint Venture Acquires Las Vegas Multifamily Property
-
ProPhotonix Announces Holding(s) in Company
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $16 at Cantor Fitzgerald
-
Tiberius Acquisition Corp (TIBR) Prices 15M Share IPO at $10/Sh
-
ProPhotonix Announces Grant of Options
-
Tiberius Acquisition Corporation Announces Pricing of $150,000,000 Initial Public Offering
-
Healthcare Realty Trust (HR) PT Lowered to $34 at Cantor Fitzgerald Citing Interest Rate Volatility
-
Cala Corporation Signs Agreement with Cosco Dalian Shipyard
-
Virtusa (VRTU) PT Raised to $60 at Cantor Fitzgerald
-
Prophotonix Announces Preliminary Results For The Year Ended December 31, 2017
-
Cantor Fitzgerald Starts R1 RCM Inc (RCM) at Overweight
-
Auryn Resources Announces US$8.5 Million Financing
-
Cantor Fitzgerald Remains Bullish on Aquinox Pharma (AQXP) Following 4Q
-
Coupa Software (COUP) PT Raised to $58 at Cantor Fitzgerald
-
Corbus Pharmaceuticals (CRBP) PT Raised to $32 at Cantor Fitzgerald
-
Advaxis (ADXS) PT Lowered to $5 at Cantor Fitzgerald; 'Hold on Durvalumab Trial'
-
Egalet Ltd (EGLT) PT Lowered to $3.50 at Cantor Fitzgerald
-
Amarin (AMRN): Outcomes Design Comparisons Are Overdone - Cantor Fitzgerald
-
Aclaris Therapeutis (ACRS): Eskata and Pipeline Should Drive Shares Higher - Cantor Fitzgerald
-
LSI Corporation (LSI) PT Lowered to $84 at Cantor Fitzgerald
-
Extra Space Storage (EXR) PT Raised to $86 at Cantor Fitzgerald
-
Global Medical REIT (GMRE) PT Lowered to $10 at Cantor Fitzgerald; 'Acquisitions Accelerating'
-
Sunesis Pharmaceuticals Inc. (SNSS) PT Raised to $4 at Cantor Fitzgerald
-
Form 4 NEWMARK GROUP, INC. For: Mar 06 Filed by: CANTOR FITZGERALD, L. P.
-
U.S. Physical Therapy (USPH) PT Raised to $90 at Cantor Fitzgerald
-
Orchid Island Capital Announces March 2018 Monthly Dividend and February 28, 2018 RMBS Portfolio Characteristics
-
Mudrick Capital Acquisition Corporation Class A Common Stock And Warrants To Commence Trading Separately On March 12, 2018

